Genesee Valley Trust Co. decreased its stake in Mead Johnson Nutrition Co. (NYSE:MJN) by 3.4% during the second quarter, Holdings Channel reports. The fund owned 3,602 shares of the company’s stock after selling 125 shares during the period. Genesee Valley Trust Co.’s holdings in Mead Johnson Nutrition were worth $327,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC raised its stake in shares of Mead Johnson Nutrition by 0.5% in the first quarter. Geode Capital Management LLC now owns 1,580,432 shares of the company’s stock worth $134,026,000 after buying an additional 7,865 shares in the last quarter. Holowesko Partners Ltd. raised its stake in shares of Mead Johnson Nutrition by 5.1% in the first quarter. Holowesko Partners Ltd. now owns 1,351,743 shares of the company’s stock worth $114,858,000 after buying an additional 66,000 shares in the last quarter. Bank of Montreal Can bought a new stake in shares of Mead Johnson Nutrition during the second quarter worth about $101,332,000. UBS Asset Management Americas Inc. raised its stake in shares of Mead Johnson Nutrition by 38.7% in the first quarter. UBS Asset Management Americas Inc. now owns 684,932 shares of the company’s stock worth $58,199,000 after buying an additional 190,967 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. raised its stake in shares of Mead Johnson Nutrition by 0.3% in the second quarter. NN Investment Partners Holdings N.V. now owns 624,227 shares of the company’s stock worth $56,649,000 after buying an additional 1,603 shares in the last quarter. 96.93% of the stock is owned by institutional investors.

Shares of Mead Johnson Nutrition Co. (NYSE:MJN) traded up 1.42% during trading on Thursday, reaching $79.25. 1,181,439 shares of the company’s stock were exchanged. Mead Johnson Nutrition Co. has a 12-month low of $65.53 and a 12-month high of $94.40. The company has a market capitalization of $14.63 billion, a P/E ratio of 29.82 and a beta of 1.17. The stock has a 50-day moving average price of $83.30 and a 200 day moving average price of $84.69.

Mead Johnson Nutrition (NYSE:MJN) last issued its earnings results on Thursday, July 28th. The company reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.78 by $0.10. Mead Johnson Nutrition had a negative return on equity of 194.30% and a net margin of 13.28%. The business earned $941.50 million during the quarter, compared to the consensus estimate of $967.25 million. During the same period last year, the company earned $0.76 EPS. The company’s revenue for the quarter was down 8.8% on a year-over-year basis. Equities analysts expect that Mead Johnson Nutrition Co. will post $3.49 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Monday, September 19th will be paid a $0.4125 dividend. This represents a $1.65 dividend on an annualized basis and a dividend yield of 2.08%. The ex-dividend date of this dividend is Thursday, September 15th. Mead Johnson Nutrition’s dividend payout ratio (DPR) is presently 62.03%.

MJN has been the subject of a number of recent analyst reports. Susquehanna reissued a “hold” rating and set a $95.00 target price on shares of Mead Johnson Nutrition in a research note on Monday, August 29th. Credit Suisse Group AG set a $100.00 price objective on Mead Johnson Nutrition and gave the company a “buy” rating in a report on Monday, September 12th. Citigroup Inc. decreased their price objective on Mead Johnson Nutrition from $106.00 to $103.00 and set a “buy” rating for the company in a report on Thursday, September 8th. Societe Generale downgraded Mead Johnson Nutrition from a “buy” rating to a “hold” rating and decreased their price objective for the company from $100.00 to $95.00 in a report on Friday, July 29th. Finally, Zacks Investment Research downgraded Mead Johnson Nutrition from a “buy” rating to a “hold” rating in a report on Monday, June 13th. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $95.75.

In other news, Director Kimberly A. Casiano sold 710 shares of the stock in a transaction on Monday, August 15th. The stock was sold at an average price of $89.75, for a total transaction of $63,722.50. Following the completion of the transaction, the director now directly owns 7,110 shares in the company, valued at approximately $638,122.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Graciela Monteagudo sold 45,873 shares of the stock in a transaction on Friday, August 5th. The stock was sold at an average price of $87.64, for a total value of $4,020,309.72. Following the transaction, the senior vice president now owns 13,800 shares of the company’s stock, valued at $1,209,432. The disclosure for this sale can be found here. 0.50% of the stock is owned by company insiders.

Mead Johnson Nutrition Company Profile

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Want to see what other hedge funds are holding MJN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mead Johnson Nutrition Co. (NYSE:MJN).

Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.